Figure 3 | Scientific Reports

Figure 3

From: Prognostic value of neutrophil-to-lymphocyte ratio in human epidermal growth factor receptor 2-negative breast cancer patients who received neoadjuvant chemotherapy

Figure 3

Prognostic ability of the combined with pCR and baseline NLR. Kaplan–Meier curves of (A) DFS in all patients, (B) OS in all patients, (C) DFS in HR+HER2− breast cancer, (D) OS in HR+HER2− breast cancer, (E) DFS in TNBC, (F) OS in TNBC. DFS disease-free survival, OS overall survival, HR hormone receptor, HER2 human epidermal growth factor receptor 2, TNBC triple-negative breast cancer, NS not significant. *P < 0.05; **P < 0.001. All graphs were prepared using the software Graphpad Prism Version 8 (GraphPad Software, USA, https://www.graphpad.com/scientific-software/prism/).

Back to article page